Nanotechnology in Antiviral Therapies
8 June 2007A new report by Research and Markets, “Antiviral Therapeutics - technologies, markets and companies,” delivers an in-depth discussion of antiviral technologies, including the impact of Nanotechnology in antiviral delivery mechanisms.
The report discusses the use of NanoViricides. These are what are known as polymeric micelles, nano-sized polymer structures that convey medicine in the bloodstream in a time-release fashion. In addition to delivering vaccines they can target and destroy viruses as well. These polymeric micelles are more effective than oral intake of medicines for a number of reasons. They can allow for an increase in the dosage of drugs that are poorly water soluble.
NanoViricides can withstand any of the body’s host defenses, which would normally render medicine ineffectual in some patients. Thus, the polymeric micelles can provide a more concentrated and focused delivery of antiviral medicine. The report presents a comparison of these types of delivery mechanisms against other types of antiviral therapies as well.
The report points out that resistance to anti-influenza therapies can develop and therefore there is a need for increased research in these areas. Some of the more speculative possibilities being discussed aim to block the virus before it fuses with the cell structure. Nanotechnology will no doubt be involved at this level as an enabling mechanism. Hepatitis, Herpes, HIV/AIDS viruses are discussed in the report, along with an optimistic prognosis for more effective treatment and ultimately cure. An abstract of the report can be read at http://www.researchandmarkets.com/reportinfo.asp?report_id=471561.
Related Posts:
Top Of Page | Trackback
If you found this page useful, consider linking to it. Simply copy and paste the code below into your web site.
It will look like this: Nanotechnology in Antiviral Therapies
